Selexipag
Selexipag is an active ingredient in 36 FDA-listed drug products sold under 2 names.
Drugs containing Selexipag
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 46014-0602 | Selexipag Capsule | .2 mg/1 | Excella GmbH & Co. KG |
| 46014-0621 | Selexipag Capsule | .2 mg/1 | Excella GmbH & Co. KG |
| 46014-0608 | Selexipag Capsule | .8 mg/1 | Excella GmbH & Co. KG |
| 70771-1793 | Selexipag Tablet, Film Coated | 200 ug/1 | Zydus Lifesciences Limited |
| 70771-1795 | Selexipag Tablet, Film Coated | 600 ug/1 | Zydus Lifesciences Limited |
| 70771-1799 | Selexipag Tablet, Film Coated | 1400 ug/1 | Zydus Lifesciences Limited |
| 70771-1796 | Selexipag Tablet, Film Coated | 800 ug/1 | Zydus Lifesciences Limited |
| 70771-1794 | Selexipag Tablet, Film Coated | 400 ug/1 | Zydus Lifesciences Limited |
| 70771-1800 | Selexipag Tablet, Film Coated | 1600 ug/1 | Zydus Lifesciences Limited |
| 70771-1798 | Selexipag Tablet, Film Coated | 1200 ug/1 | Zydus Lifesciences Limited |
| 70771-1797 | Selexipag Tablet, Film Coated | 1000 ug/1 | Zydus Lifesciences Limited |
| 70710-1556 | Selexipag Tablet, Film Coated | 1200 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1552 | Selexipag Tablet, Film Coated | 400 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1551 | Selexipag Tablet, Film Coated | 200 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1558 | Selexipag Tablet, Film Coated | 1600 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1557 | Selexipag Tablet, Film Coated | 1400 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1553 | Selexipag Tablet, Film Coated | 600 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1554 | Selexipag Tablet, Film Coated | 800 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1555 | Selexipag Tablet, Film Coated | 1000 ug/1 | Zydus Pharmaceuticals (USA) Inc. |
| 66215-718 | Uptravi Injection, Powder, For Solution | 1800 ug/10mL | Actelion Pharmaceuticals US, Inc. |
| 66215-616 | Uptravi Tablet, Coated | 1600 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-608 | Uptravi Tablet, Coated | 800 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-610 | Uptravi Tablet, Coated | 1000 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-612 | Uptravi Tablet, Coated | 1200 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-604 | Uptravi Tablet, Coated | 400 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-915 | Uptravi Tablet, Film Coated | 150 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-602 | Uptravi Tablet, Coated | 200 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-614 | Uptravi Tablet, Coated | 1400 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-910 | Uptravi Tablet, Film Coated | 100 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 66215-606 | Uptravi Tablet, Coated | 600 ug/1 | Actelion Pharmaceuticals US, Inc. |
| 46014-6120 | Uptravi Capsule | 1.2 mg/1 | Excella GmbH & Co. KG |
| 46014-6100 | Uptravi Capsule | 1 mg/1 | Excella GmbH & Co. KG |
| 46014-6160 | Uptravi Capsule | 1.6 mg/1 | Excella GmbH & Co. KG |
| 46014-6040 | Uptravi Capsule | .4 mg/1 | Excella GmbH & Co. KG |
| 46014-6140 | Uptravi Capsule | 1.4 mg/1 | Excella GmbH & Co. KG |
| 46014-6060 | Uptravi Capsule | .6 mg/1 | Excella GmbH & Co. KG |